Two Sigma Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,200
Closed -$342K 3447
2024
Q1
$342K Buy
+18,200
New +$312K ﹤0.01% 1854
2023
Q3
Sell
-16,000
Closed -$333K 3316
2023
Q2
$333K Buy
16,000
+7,400
+86% +$161K 0.01% 1781
2023
Q1
$202K Buy
+8,600
New +$231K ﹤0.01% 2087

Other funds holding OGN

Two Sigma Securities's OGN Position: Q1 2026 in Review

Two Sigma Securities sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 39,951 shares — an estimated $286K sold.

Two Sigma Securities first reported a position in OGN in Q3 2022 and held it in 6 quarters. The position peaked at $366K in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Two Sigma Securities reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 39,951 Organon & Co shares in Q1 2026, an estimated $286K.
  • Two Sigma Securities first reported a position in Organon & Co in Q3 2022 and held it in 6 quarters.
  • Two Sigma Securities's Organon & Co position peaked at $366K in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.